ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382035 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382035; 2) Community: the network communities that were significantly associated with the response to NSC 382035; 3) Molecule: the relationships between components within communities and NSC 382035; 4) MDR: the compounds that were significantly associated with the NSC 382035.

NSC Compound Enrichment Correlation
NSC 674103 2-Acetylimidazo[4,5-b]pyridin 4 p-chlorophenyl 3 thiosemicarbazone 0.00838963112864943 0.28764913
NSC 685285 Null 0.00838963112864943 0.29746022
NSC 6926 Null 0.00838963112864943 0.36822576
NSC 697535 Null 0.00838963112864943 0.62617826
NSC 709974 Null 0.00838963112864943 0.52630716
NSC 718781 Erlotinib hydrochloride 0.00838963112864943 -0.1734218
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.00838963112864943 0.079358179
NSC 725098 Null 0.00838963112864943 0.59170591
NSC 726217 Combretastatin A4-analogue 0.00838963112864943 0.48487963
NSC 117281 ANTINEOPLASTIC-117281 0.00888636978630776 0.40874297
Total:112  Current:27    [First] [Prev] [Next] [Last]